Press release
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1%
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices play a critical role in seizure detection and monitoring, offering hope and improved quality of life for millions affected by epilepsy worldwide. With advancements in technology, including deep brain stimulation (DBS), vagus nerve stimulation (VNS), and responsive neurostimulation (RNS), coupled with innovative wearable and conventional devices, the landscape of epilepsy management is rapidly evolving.
Epilepsy Devices Market Trends are rise in the geriatric population who are more susceptible to developing neurological diseases, a rise in the adoption of technologically advanced epilepsy devices, and an increase in awareness toward the benefits of using epilepsy devices in the effective diagnosis of seizures. For instance, according to National Health Service, epilepsy starts in people aged over 60 years. Furthermore, cryptogenic or stroke-related seizures are most common in elderly people.
๐๐๐ฒ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ: The market showcases a diverse range of products, including conventional and wearable devices, EEG, Electrocardiography (EKG), Surface Electromyography (sEMG), Video Detection Systems, and more, catering to varied patient needs.
โ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ: With a forecast period spanning from 2021 to 2031, the report provides a comprehensive analysis of market dynamics, identifying key drivers, restraints, and opportunities shaping the epilepsy devices market.
โ ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: Major countries in each region are mapped based on their revenue contribution to the global market, providing valuable insights for stakeholders worldwide.
โ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐: Key market players such as Medpage Ltd, Abbott Laboratories, Empatica, Inc., Natus Medical Incorporated, and others are positioned strategically, enabling benchmarking and fostering a deeper understanding of market dynamics.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A14821
๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ-
โ Cadwell Industries
โ Natus Medical Compumedics Limited
โ Empatica Inc.
โ LivaNova PLC
โ Masimo Corporation
โ Medpage Ltd.
โ Medtronic plc
โ Boston Scientific Corporation
โ Abbott Laboratories
๐๐ญ๐๐ค๐๐ก๐จ๐ฅ๐๐๐ซ๐ฌ ๐๐ญ๐๐ง๐ ๐ญ๐จ ๐๐๐ง๐๐๐ข๐ญ ๐๐ซ๐จ๐ฆ:
โ Quantitative analysis of market segments and current trends
โ Insights into prevailing market opportunities
โ Porter's five forces analysis for profit-oriented business decisions
โ Identification of key growth strategies and application areas
With an emphasis on innovation and patient-centric care, the epilepsy devices market is poised for significant growth, revolutionizing epilepsy management globally.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ, ๐๐๐ฌ๐ญ๐ซ๐๐ข๐ง๐ญ๐ฌ, ๐๐ง๐ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ-
Rise in the prevalence of old age population that are more vulnerable to epilepsy and increase in awareness regarding the use of epilepsy devices drives the growth of the global epilepsy devices market. On the other hand, strict government regulations concerning the manufacturing of epilepsy device products and product approvals impede the growth to some extent. However, increase in focus on developing cost-effective epilepsy devices and surge in R&D investments in the discovery & development of advanced epilepsy devices are expected to create lucrative opportunities in the industry.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1% here
News-ID: 3434530 • Views: โฆ
More Releases from Allied Market Research (AMR)

Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521
Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโฆ

Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849
Market Drivers and Challenges:
- The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โฆ

Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654
What is Sunflower Lecithin?
Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโฆ

Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156
Market Drivers, Restraints, and Opportunities
Drivers:
- Technological advancements and innovations inโฆ
More Releases for Epilepsy
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Globalโฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
โข Idexx Laboratories Inc.
โข PBD Biotech Ltd
โข Thermo Fisher Scientific Inc.
โข Innovative Diagnostics SAS
โข Neogen Corp
โข Enfer Labs
โข bioMerieux SA
โข Ring Biotechnology Co Ltd
โข Bionote Inc.
โข Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or ifโฆ
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aimsโฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
Thisโฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโฆ
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasingโฆ